Gaelle Pierron
Gaelle Pierron
PhD. Responsable Adjoint Unité Génétique Somatique Institut Curie Paris
Adresse e-mail validée de
Citée par
Citée par
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
I Janoueix-Lerosey, D Lequin, L Brugieres, A Ribeiro, L de Pontual, ...
Nature 455 (7215), 967-970, 2008
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma
D Williamson, E Missiaglia, A de Reynies, G Pierron, B Thuille, ...
J Clin Oncol 28 (13), 2151-8, 2010
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
G Pierron, F Tirode, C Lucchesi, S Reynaud, S Ballet, S Cohen-Gogo, ...
Nature genetics 44 (4), 461-466, 2012
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations
F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ...
Cancer discovery 4 (11), 1342-1353, 2014
Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-EWING 99 trial
MC Le Deley, O Delattre, KL Schaefer, SA Burchill, G Koehler, ...
J Clin Oncol 28 (12), 1982-8, 2010
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
A Vincent-Salomon, N Gruel, C Lucchesi, G MacGrogan, R Dendale, ...
Breast Cancer Research 9 (2), R24, 2007
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
R Lebofsky, C Decraene, V Bernard, M Kamal, A Blin, Q Leroy, TR Frio, ...
Molecular oncology 9 (4), 783-790, 2015
PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
E Missiaglia, D Williamson, J Chisholm, P Wirapati, G Pierron, F Petel, ...
Journal of Clinical Oncology 30 (14), 1670-1677, 2012
Two types of chromosome 1p losses with opposite significance in gliomas
A Idbaih, Y Marie, G Pierron, C Brennetot, K Hoang‐Xuan, M Kujas, ...
Annals of neurology 58 (3), 483-487, 2005
High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors
E Manié, A Vincent-Salomon, J Lehmann-Che, G Pierron, E Turpin, ...
Cancer research 69 (2), 663-671, 2009
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast
A Vincent-Salomon, C Lucchesi, N Gruel, V Raynal, G Pierron, ...
Clinical cancer research 14 (7), 1956-1965, 2008
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor
F Bourdeaut, D Lequin, L Brugières, S Reynaud, C Dufour, F Doz, ...
Clinical Cancer Research 17 (1), 31-38, 2011
Accumulation of segmental alterations determines progression in neuroblastoma
G Schleiermacher, I Janoueix-Lerosey, A Ribeiro, J Klijanienko, ...
Journal of Clinical Oncology 28 (19), 3122-3130, 2010
Emergence of New ALK Mutations at Relapse of Neuroblastoma
G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, ...
Journal of clinical oncology 32 (25), 2727-2734, 2014
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
S Postel-Vinay, AS Véron, F Tirode, G Pierron, S Reynaud, H Kovar, ...
Nature genetics 44 (3), 323-327, 2012
hSNF5/INI1‐deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities
F Bourdeaut, P Freneaux, B Thuille, A Lellouch‐Tubiana, A Nicolas, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007
VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles
PL Rosa, E Viara, P Hupé, G Pierron, S Liva, P Neuvial, I Brito, S Lair, ...
Bioinformatics 22 (17), 2066-2073, 2006
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
A Idbaih, Y Marie, C Lucchesi, G Pierron, E Manié, V Raynal, V Mosseri, ...
International Journal of Cancer 122 (8), 1778-1786, 2008
Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas
P Lagarde, J Przybyl, C Brulard, G Pérot, G Pierron, O Delattre, R Sciot, ...
Journal of clinical oncology 31 (5), 608-615, 2013
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas
E Missiaglia, CJ Shepherd, S Patel, K Thway, G Pierron, ...
British journal of cancer 102 (12), 1769-1777, 2010
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20